Breast Cancer Drug Shows Promise in Combination Therapy for Ewing Sarcoma
Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, reported St. Jude Children's Research Hospital scientists. The study will appear in the November 6 edition of the scientific journal Cell Reports. (Source: Disabled World)
Source: Disabled World - October 28, 2014 Category: Disability Tags: Medical Research Source Type: news
Breast Cancer Drug Shows Promise in Combination Therapy for Ewing Sarcoma
Researchers have identified a promising new triple-drug combination therapy that exploits DNA repair problem in Ewing sarcoma tumors (Source: Disabled World)
Source: Disabled World - October 28, 2014 Category: Disability Tags: Medical Research Source Type: news
Experimental Breast Cancer Drug Holds Promise in Combination Therapy...
St. Jude Children’s Research Hospital researchers have identified a promising new triple-drug combination therapy that exploits DNA repair problem in Ewing sarcoma tumors; clinical trials expected to...(PRWeb October 23, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12273480.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 24, 2014 Category: Pharmaceuticals Source Type: news
Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma
Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, report researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 23, 2014 Category: Science Source Type: news
Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma
(St. Jude Children's Research Hospital) Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, reported St. Jude Children's Research Hospital scientists. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2014 Category: Global & Universal Source Type: news
Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma
St. Jude Children’s Research Hospital researchers have identified a promising new triple-drug combination therapy that exploits DNA repair problem in Ewing sarcoma tumors; clinical trials expected to open soon. (Michael Dyer, PhD, Anang Shelat, PhD, Elizabeth Stewart, MD) (Source: St. Jude Children's Research Hospital)
Source: St. Jude Children's Research Hospital - October 23, 2014 Category: Pediatrics Source Type: news
